《液體平衡和死亡率》ppt課件(文件)
【正文】 e with 60day mortality in patients who developed AKI, as defined by the AKI Network criteria. The Fluid and Catheter Treatment Trial (FACTT) ? was the largest and only multicenter trial of a fluidrestrictive management strategy for the treatment of acute lung injury (ALI) . ? Although there was no demonstrated mortality benefit, the fluidrestrictive management strategy was associated with an increased number of ventilatorfree days and a trend toward a reduced requirement for renal replacement therapy. Results ? 306 patients developed AKI in the first 2 study days and were included in our analysis.
教學課件相關(guān)推薦
鄂ICP備17016276號-1